Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur-uracil with CMF (N·SAS-BC 01 trial and CUBC trial).

Breast Cancer Res Treat · 2021 · PMC7940338 · PMID 33259001

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significancep = 0.07so close (0.05 < p ≤ 0.1)

Although it did not reach statistical significance, RFS in patients treated with UFT tended to be longer in patients with HR−/HER2+ subtype (hazard ratio 0.38 [0.13–1.09], p = 0.07) and in patients with high TILs levels (hazard ratio 0.24 [0.05–1.10], p = 0.07).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.